Recent advances in immunopathophysiology of interleukin-6: an innovative therapeutic drug, tocilizumab (recombinant humanized anti-human interleukin-6 receptor antibody), unveils the mysterious etiology of immune-mediated inflammatory diseases (Q36989376)
Jump to navigation
Jump to search
scientific article published on November 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Recent advances in immunopathophysiology of interleukin-6: an innovative therapeutic drug, tocilizumab (recombinant humanized anti-human interleukin-6 receptor antibody), unveils the mysterious etiology of immune-mediated inflammatory diseases |
scientific article published on November 2007 |
Statements
1 reference
Recent advances in immunopathophysiology of interleukin-6: an innovative therapeutic drug, tocilizumab (recombinant humanized anti-human interleukin-6 receptor antibody), unveils the mysterious etiology of immune-mediated inflammatory diseases (English)
1 reference
Yoshiyuki Ohsugi
1 reference
1 November 2007
1 reference
1 reference
30
1 reference
11
1 reference
2001-2006
1 reference
1 reference
Identifiers
1 reference
1 reference